MedPath

EFFEPHARM LTD

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Evaluate the Safety, Tolerability, and Efficacy of UthPeak NMNH (Reduced Nicotinamide Mononucleotide) in Healthy Adult Participants

Not Applicable
Completed
Conditions
Healthy Aging
First Posted Date
2025-03-21
Last Posted Date
2025-07-04
Lead Sponsor
EffePharm LTD
Target Recruit Count
80
Registration Number
NCT06889740
Locations
🇮🇳

Medstar Speciality Hospital, Bengaluru, Karnataka, India

🇮🇳

Vinayaka Mission's Medical College and Hospital, Karaikal, Puducherry, India

Evaluate the Efficacy and Safety of Uthever NMN(Nicotinamide Mononucleotide, a Form of Vitamin B3)

Not Applicable
Completed
Conditions
Aging
First Posted Date
2020-01-14
Last Posted Date
2021-04-01
Lead Sponsor
EffePharm LTD
Target Recruit Count
66
Registration Number
NCT04228640
Locations
🇮🇳

Dr Kamalakar Gajarae, Pune, Maharashtra, India

🇮🇳

Swasthiye Clinic and Research Center, Pune, Maharashtra, India

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.